适应证-话题@MedSci

#适应证#

55篇内容 | 1250人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1893603, encodeId=18401893603e8, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=帕博利珠单抗斩获小细胞肺癌治疗适应证, objectType=article, longId=168856, objectId=a17e168856d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a17e168856d1, replyNumber=0, likeNumber=31, createdTime=2019-09-03, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a17e168856d1, moduleTitle=帕博利珠单抗斩获小细胞肺癌治疗适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a17e168856d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893602, encodeId=62e91893602d6, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=2019 SFORL指南：成人耳蜗植入术的适应证, objectType=article, longId=165744, objectId=fa99165e448b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa99165e448b, replyNumber=0, likeNumber=18, createdTime=2019-05-15, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa99165e448b, moduleTitle=2019 SFORL指南：成人耳蜗植入术的适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa99165e448b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893598, encodeId=cee81893598e4, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=乳腺癌手术的适应证与禁忌证有哪些？, objectType=article, longId=155579, objectId=b2061555e913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2061555e913, replyNumber=0, likeNumber=35, createdTime=2019-06-26, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2061555e913, moduleTitle=乳腺癌手术的适应证与禁忌证有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2061555e913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893594, encodeId=b3c8189359412, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=2018 EANM程序指南：白细胞和抗粒细胞单克隆抗体闪烁显像技术的临床适应证，图像采集和数据解释, objectType=article, longId=140200, objectId=7a4414020078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a4414020078, replyNumber=0, likeNumber=17, createdTime=2019-01-14, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a4414020078, moduleTitle=2018 EANM程序指南：白细胞和抗粒细胞单克隆抗体闪烁显像技术的临床适应证，图像采集和数据解释, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a4414020078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893599, encodeId=18191893599d0, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=【1946】【重磅盘点】2018年，FDA又批准了哪些血液肿瘤相关新药？又新增哪些适应证？, objectType=article, longId=155800, objectId=42a41558008f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42a41558008f, replyNumber=0, likeNumber=26, createdTime=2019-01-04, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42a41558008f, moduleTitle=【1946】【重磅盘点】2018年，FDA又批准了哪些血液肿瘤相关新药？又新增哪些适应证？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42a41558008f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893596, encodeId=7e39189359659, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=开创机器人手术新的适应证北京和睦家医院是如何做到的, objectType=article, longId=150671, objectId=dadc1506e17d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dadc1506e17d, replyNumber=0, likeNumber=34, createdTime=2019-06-04, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dadc1506e17d, moduleTitle=开创机器人手术新的适应证北京和睦家医院是如何做到的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dadc1506e17d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893597, encodeId=85f8189359e6d, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=2018 ACOG委员会意见：盆腔常规检查的效用和适应证（No.754）, objectType=article, longId=151138, objectId=b3401511385f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3401511385f, replyNumber=0, likeNumber=26, createdTime=2019-03-06, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3401511385f, moduleTitle=2018 ACOG委员会意见：盆腔常规检查的效用和适应证（No.754）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3401511385f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893595, encodeId=1d991893595c9, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证, objectType=article, longId=142310, objectId=66f314231017, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66f314231017, replyNumber=0, likeNumber=19, createdTime=2018-11-15, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66f314231017, moduleTitle=2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66f314231017)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893592, encodeId=0fd6189359258, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=JAMA Intern Med：已获批药物新适应证申请可使用数据库研究, objectType=article, longId=128426, objectId=2e681284268f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e681284268f, replyNumber=0, likeNumber=25, createdTime=2018-12-16, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e681284268f, moduleTitle=JAMA Intern Med：已获批药物新适应证申请可使用数据库研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e681284268f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893591, encodeId=485818935918d, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=宫颈癌淋巴结切除适应证和争议, objectType=article, longId=125731, objectId=3db9125e3127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3db9125e3127, replyNumber=0, likeNumber=30, createdTime=2018-09-21, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3db9125e3127, moduleTitle=宫颈癌淋巴结切除适应证和争议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3db9125e3127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893590, encodeId=8cb6189359006, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=牵拉成骨延长手术的适应证如何选择？, objectType=article, longId=122562, objectId=6b8812256268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b8812256268, replyNumber=0, likeNumber=27, createdTime=2018-02-25, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b8812256268, moduleTitle=牵拉成骨延长手术的适应证如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b8812256268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893593, encodeId=0f8b1893593b1, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=2018 AHA科学声明：颅内血管内神经介入手术的适应证, objectType=article, longId=136278, objectId=8b1e1362e8c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b1e1362e8c8, replyNumber=0, likeNumber=29, createdTime=2018-11-27, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b1e1362e8c8, moduleTitle=2018 AHA科学声明：颅内血管内神经介入手术的适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b1e1362e8c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893589, encodeId=d3dd1893589b2, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=疗效相当，更少出血风险，达比加群酯新适应证在中国获批, objectType=article, longId=118824, objectId=59b51188242b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59b51188242b, replyNumber=0, likeNumber=33, createdTime=2018-03-27, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59b51188242b, moduleTitle=疗效相当，更少出血风险，达比加群酯新适应证在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59b51188242b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893588, encodeId=f9e91893588ed, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=Pharmacotherapy：抗精神病药超说明书用于心理健康适应证是否适当, objectType=article, longId=98967, objectId=9cf49896e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cf49896e23, replyNumber=0, likeNumber=48, createdTime=2017-07-14, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cf49896e23, moduleTitle=Pharmacotherapy：抗精神病药超说明书用于心理健康适应证是否适当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cf49896e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893587, encodeId=77e6189358eda, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, objectType=article, longId=64673, objectId=6448646e38c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6448646e38c, replyNumber=0, likeNumber=41, createdTime=2017-02-15, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6448646e38c, moduleTitle=5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6448646e38c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893586, encodeId=409e189358645, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=马长生：房颤抗凝治疗适应证新认识, objectType=article, longId=55010, objectId=0d3355010c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d3355010c0, replyNumber=0, likeNumber=37, createdTime=2015-11-16, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d3355010c0, moduleTitle=马长生：房颤抗凝治疗适应证新认识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d3355010c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893585, encodeId=b8ff189358518, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=中国急性缺血性脑卒中早期血管内介入诊疗指南——介入治疗适应证和禁忌证, objectType=article, longId=52051, objectId=2269520516b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2269520516b, replyNumber=0, likeNumber=43, createdTime=2015-10-03, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2269520516b, moduleTitle=中国急性缺血性脑卒中早期血管内介入诊疗指南——介入治疗适应证和禁忌证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2269520516b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893584, encodeId=38e01893584e7, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=JAMA Intern Med：女性接受CRT-D治疗的适应证应扩大？, objectType=article, longId=37251, objectId=98913e2517c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98913e2517c, replyNumber=0, likeNumber=31, createdTime=2014-10-21, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98913e2517c, moduleTitle=JAMA Intern Med：女性接受CRT-D治疗的适应证应扩大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98913e2517c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893582, encodeId=2fdf189358293, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=FDA扩美敦力CRT适应证, objectType=article, longId=33444, objectId=1937334448f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1937334448f, replyNumber=0, likeNumber=29, createdTime=2014-05-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1937334448f, moduleTitle=FDA扩美敦力CRT适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1937334448f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893583, encodeId=b9f01893583bf, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=OCC 2014：TAVR稳步发展适应证级别不断提升, objectType=article, longId=36061, objectId=a22036061d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22036061d7, replyNumber=0, likeNumber=33, createdTime=2015-01-15, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22036061d7, moduleTitle=OCC 2014：TAVR稳步发展适应证级别不断提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22036061d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

适应证

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

帕博利珠单抗斩获小细胞肺癌治疗适应证

2019-09-03

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

2019 SFORL指南：成人耳蜗植入术的适应证

2019-05-15

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

乳腺癌手术的适应证与禁忌证有哪些？

2019-06-26

智智灵药 (审核中...)

前往app查看评论内容

#适应证#

2018 EANM程序指南：白细胞和抗粒细胞单克隆抗体闪烁显像技术的临床适应证，图像采集和数据解释

2019-01-14

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

【1946】【重磅盘点】2018年，FDA又批准了哪些血液肿瘤相关新药？又新增哪些适应证？

2019-01-04

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

开创机器人手术新的适应证北京和睦家医院是如何做到的

2019-06-04

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

2018 ACOG委员会意见：盆腔常规检查的效用和适应证（No.754）

2019-03-06

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证

2018-11-15

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

JAMA Intern Med：已获批药物新适应证申请可使用数据库研究

2018-12-16

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

宫颈癌淋巴结切除适应证和争议

2018-09-21

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

牵拉成骨延长手术的适应证如何选择？

2018-02-25

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

2018 AHA科学声明：颅内血管内神经介入手术的适应证

2018-11-27

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

疗效相当，更少出血风险，达比加群酯新适应证在中国获批

2018-03-27

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

Pharmacotherapy：抗精神病药超说明书用于心理健康适应证是否适当

2017-07-14

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）

2017-02-15

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

马长生：房颤抗凝治疗适应证新认识

2015-11-16

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

中国急性缺血性脑卒中早期血管内介入诊疗指南——介入治疗适应证和禁忌证

2015-10-03

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

JAMA Intern Med：女性接受CRT-D治疗的适应证应扩大？

2014-10-21

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

FDA扩美敦力CRT适应证

2014-05-17

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

OCC 2014：TAVR稳步发展适应证级别不断提升

2015-01-15

科室
- - 订阅+
  - 更多科室
工具
服务